SureSwab®, Advanced Vaginitis Plus, TMA
Test Code: 10120
CPT Code(s): 81513, 87481 (x2), 87661, 87491, 87591
Includes:
Test Code: 10120
CPT Code(s): 81513, 87481 (x2), 87661, 87491, 87591
Includes:
Test code: 19550
Note: For male specimens, see Trichomonas Vaginalis RNA, Qualitative TMA, Males (test code 90801)
CPT code(s): 87661
Methodology: Transcription Mediated amplification (TMA)
Test code: 19550
Note: For male specimens, see Trichomonas Vaginalis RNA, Qualitative TMA, Males (test code 90801).
CPT code(s): 87661
Methodology Transcription: Mediated amplification (TMA)
Test code: 19550
Note: For male specimens, see Trichomonas Vaginalis RNA, Qualitative TMA, Males (test code 90801).
CPT code(s): 87661
Methodology transcription: Mediated amplification (TMA)
Reference range(s):
| T. vaginalis RNA, QL TMA | Not detected |
This test was performed using the Aptima® Trichomonas vaginalis Assay (GEN-PROBE®).
| Test Code | Test Name | CPT Code |
| 18810 | Pap | 88175 (HCPCS: G0145) |
| 18811 | Pap reflex HPV mRNA E6/E7 (age <21) | 88175 (HCPCS: G0145) |
| 18813 | Pap and HPV mRNA E6/E7 ages 30-65) | 88175 (HCPCS: G0145), 87624 |
| 18828 | Pap and HPV mRNA E6/E7,C. trachomatis, N. gonorrhoeae | 88175 (HCPCS: G0145), 87624, 87491, 87591 |
| 18829 |
| Test Code | Test Name | CPT Code |
| 18810 | Pap | 88175 (HCPCS: G0145) |
| 18811 | Pap reflex HPV mRNA E6/E7 (age <21) | 88175 (HCPCS: G0145) |
| 18813 | Pap and HPV mRNA E6/E7 ages 30-65) | 88175 (HCPCS: G0145), 87624 |
| 18828 | Pap and HPV mRNA E6/E7,C. trachomatis, N. gonorrhoeae | 88175 (HCPCS: G0145), 87624, 87491, 87591 |
| 18829 |
Test Code: 10553
CPT Code(s): 87880
Includes: If Streptococcus Group A Rapid Antigen is negative, a culture will be performed at an additional charge (CPT code(s): 87081).
Methodology: Immunochromatography Bacterial Culture, Aerobic Routine Isolation and Identification Procedures
Clinical Significance: A positive result from the antigen assay or isolation of Group A streptococci by culture from a symptomatic patient is usually considered clinically significant.